Kudo, RisaYamaguchi, ManakoSekine, MasayukiAdachi, SosukeUeda, YutakaMiyagi, EtsukoHara, MegumiHanley, Sharon J. B.Enomoto, Takayuki2023-01-272023-01-272019-02-01Kudo, R, Yamaguchi, M, Sekine, M, Adachi, S, Ueda, Y, Miyagi, E, Hara, M, Hanley, S J B & Enomoto, T 2019, 'Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population : High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection', The journal of infectious diseases, vol. 219, no. 3, pp. 382-390. https://doi.org/10.1093/infdis/jiy5161537-6613RIS: urn:26C550ADE03265CB2BEC1DC89DFE8085ORCID: /0000-0002-7554-004X/work/127304256https://hdl.handle.net/2164/19929Acknowledgments.  We thank Dr Tomomi Egawa-Takata, Dr Akiko Morimoto, Dr Yusuke Tanaka, Ms Asami Yagi, Ms Yuka Watanabe, Ms Sachiko Ono, Ms Anna Ishida, and the administrators of Niigata, Nagaoka, Shibata, Sanjo, Joetsu, and Mitsuke cities for their support in conducting the survey. Financial support. This work was supported by the Health and Labor Sciences Research Grant (26272001) and the Japanese Agency for Medical Research and Development (AMED) under grant number JP15ck0106103 and JP17ck0106369.9227181engSDG 3 - Good Health and Well-beingHPV vaccineHPV infectioncervical cancervaccine effectivenesscross-protectionbivalent vaccineR MedicineRBivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population : High Vaccine-Type-Specific Effectiveness and Evidence of Cross-ProtectionJournal article10.1093/infdis/jiy5162193